Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: A systematic expression analysis
暂无分享,去创建一个
Arndt Hartmann | Peter J Wild | Glen Kristiansen | Rolando Del Maestro | G. Kristiansen | E. Dahl | R. Knuechel | A. Hartmann | P. Wild | N. Bektas | R. Del Maestro | T. Werbowetski-Ogilvie | Juergen Veeck | Edgar Dahl | Ruth Knuechel | Uwe Heindrichs | Alexander Hamm | Nuran Bektas | Tamra Werbowetski-Ogilvie | U. Heindrichs | Alexander Hamm | Juergen Veeck
[1] G. Kristiansen,et al. The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation , 2008, Oncogene.
[2] Barry Komm,et al. Estrogen-regulated gene networks in human breast cancer cells: involvement of E2F1 in the regulation of cell proliferation. , 2007, Molecular endocrinology.
[3] S. Opal,et al. Longitudinal studies of inter-alpha inhibitor proteins in severely septic patients: A potential clinical marker and mediator of severe sepsis* , 2007, Critical care medicine.
[4] Christian Pilarsky,et al. Molecular Profiling of Laser-Microdissected Matched Tumor and Normal Breast Tissue Identifies Karyopherin α2 as a Potential Novel Prognostic Marker in Breast Cancer , 2006, Clinical Cancer Research.
[5] Florian Fritzsche,et al. Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies , 2006, BMC Cancer.
[6] Glen Kristiansen,et al. Systematic characterisation of GABRP expression in sporadic breast cancer and normal breast tissue , 2006, International journal of cancer.
[7] D. Cox,et al. Extracellular matrix integrity: A possible mechanism for differential clinical effects among selective estrogen receptor modulators and estrogens? , 2006, Molecular and Cellular Endocrinology.
[8] Nada Jabado,et al. Isolation of a natural inhibitor of human malignant glial cell invasion: inter alpha-trypsin inhibitor heavy chain 2. , 2006, Cancer research.
[9] Armin A. Weiser,et al. Expression levels of the putative zinc transporter LIV‐1 are associated with a better outcome of breast cancer patients , 2005, International journal of cancer.
[10] S. Opal,et al. Inter-Alpha-Inhibitor Proteins Are Endogenous Furin Inhibitors and Provide Protection against Experimental Anthrax Intoxication , 2005, Infection and Immunity.
[11] Marilyn S. Rugg,et al. Characterization of Complexes Formed between TSG-6 and Inter-α-inhibitor That Act as Intermediates in the Covalent Transfer of Heavy Chains onto Hyaluronan* , 2005, Journal of Biological Chemistry.
[12] S. Gelling,et al. Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer , 2005, The Journal of pathology.
[13] V. Hascall,et al. Inter-α-trypsin Inhibitor, a Covalent Protein-Glycosaminoglycan-Protein Complex* , 2004, Journal of Biological Chemistry.
[14] Marilyn S. Rugg,et al. Specificity of the tumor necrosis factor-induced protein 6-mediated heavy chain transfer from inter-alpha-trypsin inhibitor to hyaluronan: implications for the assembly of the cumulus extracellular matrix. , 2004, The Journal of biological chemistry.
[15] T. Terao,et al. Genetic Down-regulation of Phosphoinositide 3-Kinase by Bikunin Correlates with Suppression of Invasion and Metastasis in Human Ovarian Cancer HRA Cells* , 2004, Journal of Biological Chemistry.
[16] Irina Klaman,et al. ITIH5, a novel member of the inter-alpha-trypsin inhibitor heavy chain family is downregulated in breast cancer. , 2004, Cancer letters.
[17] L. Ødum,et al. TSG-6 and calcium ions are essential for the coupling of inter-alpha-trypsin inhibitor to hyaluronan in human synovial fluid. , 2004, Osteoarthritis and cartilage.
[18] G. Sledge,et al. Extracellular proteolysis and cancer: meeting summary and future directions. , 2003, Cancer research.
[19] S. Opal,et al. Correlation between mortality and the levels of inter-alpha inhibitors in the plasma of patients with severe sepsis. , 2003, The Journal of infectious diseases.
[20] C. Milner,et al. TSG-6: a multifunctional protein associated with inflammation , 2003, Journal of Cell Science.
[21] J. Rakic,et al. Role of plasminogen activator-plasmin system in tumor angiogenesis , 2003, Cellular and Molecular Life Sciences CMLS.
[22] M. Suzuki,et al. The Protease Inhibitor Bikunin, a Novel Anti-Metastatic Agent , 2003, Biological chemistry.
[23] K. Kimata,et al. A physiological function of serum proteoglycan bikunin: The chondroitin sulfate moiety plays a central role , 2002, Glycoconjugate Journal.
[24] I. Chaudry,et al. Administration of human inter-alpha-inhibitors maintains hemodynamic stability and improves survival during sepsis. , 2002, Critical care medicine.
[25] L. Thiberville,et al. Inhibition of tumor growth and metastatic spreading by overexpression of inter‐alpha‐trypsin inhibitor family chains , 2002, International journal of cancer.
[26] Y. Masuho,et al. Identification of sonic hedgehog-responsive genes using cDNA microarray. , 2001, Biochemical and biophysical research communications.
[27] G. Yousef,et al. The new human tissue kallikrein gene family: structure, function, and association to disease. , 2001, Endocrine reviews.
[28] L. Diatchenko,et al. Generation of full-length cDNA libraries enriched for differentially expressed genes for functional genomics. , 2001, BioTechniques.
[29] M. Dietel,et al. Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas. , 2001, The American journal of pathology.
[30] P. Iannaccone,et al. The sonic hedgehog-patched-gli pathway in human development and disease. , 2000, American journal of human genetics.
[31] A. Blom,et al. Bikunin--not just a plasma proteinase inhibitor. , 2000, The international journal of biochemistry & cell biology.
[32] A. Piñeiro,et al. ITIH4 serum concentration increases during acute-phase processes in human patients and is up-regulated by interleukin-6 in hepatocarcinoma HepG2 cells. , 1999, Biochemical and biophysical research communications.
[33] W. J. Larsen,et al. Inter-alpha-inhibitor binding to hyaluronan in the cumulus extracellular matrix is required for optimal ovulation and development of mouse oocytes. , 1999, Biology of reproduction.
[34] Rainer M. Bohle,et al. Real-time quantitative RT–PCR after laser-assisted cell picking , 1998, Nature Medicine.
[35] F. Bost,et al. Human inter-alpha-trypsin inhibitor heavy chain H3 gene. Genomic organization, promoter analysis, and gene linkage. , 1998, The Journal of biological chemistry.
[36] D. Carter. TNM Classification of Malignant Tumors , 1998 .
[37] H. Kobayashi,et al. A bifunctional hybrid molecule of the amino-terminal fragment of urokinase and domain II of bikunin efficiently inhibits tumor cell invasion and metastasis. , 1998, European journal of biochemistry.
[38] Richard A. Szucs,et al. TNM Classification of Malignant Tumors. 5th ed , 1998 .
[39] F. Bost,et al. Inter-alpha-trypsin inhibitor proteoglycan family--a group of proteins binding and stabilizing the extracellular matrix. , 1998, European journal of biochemistry.
[40] S. Mizushima,et al. Gene expression of the two heavy chains and one light chain forming the inter-alpha-trypsin-inhibitor in human tissues. , 1998, Biological & pharmaceutical bulletin.
[41] P. Rouet,et al. The inter-alpha-inhibitor family: from structure to regulation. , 1996, The Biochemical journal.
[42] B. Cronstein,et al. TNF/IL-1-inducible protein TSG-6 potentiates plasmin inhibition by inter-alpha-inhibitor and exerts a strong anti-inflammatory effect in vivo. , 1996, Journal of immunology.
[43] H. Kobayashi,et al. Inhibition of metastasis of lewis lung carcinoma by urinary trypsin inhibitor in experimental and spontaneous metastasis models , 1995, International journal of cancer.
[44] H. Kobayashi,et al. Inhibitory Effect of a Conjugate between Human Urokinase and Urinary Trypsin Inhibitor on Tumor Cell Invasion in Vitro(*) , 1995, The Journal of Biological Chemistry.
[45] M. Diarra‐Mehrpour,et al. Post-translational processing of the inter-alpha-trypsin inhibitor in the human hepatoma HepG2 cell line. , 1994, Biochemical Journal.
[46] L. Huang,et al. A serum-derived hyaluronan-associated protein (SHAP) is the heavy chain of the inter alpha-trypsin inhibitor. , 1993, The Journal of biological chemistry.
[47] R. Maestro,et al. Three discrete regions of deletion at 3p in head and neck cancers. , 1993, Cancer research.
[48] J. Minna,et al. Molecular mapping of deletion sites in the short arm of chromosome 3 in human lung cancer , 1990, Genes, chromosomes & cancer.
[49] E. Wachter,et al. Two out of the three kinds of subunits of inter-alpha-trypsin inhibitor are structurally related. , 1989, European journal of biochemistry.
[50] G. Klein,et al. Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[51] L. Ossowski. Plasminogen activator dependent pathways inthe dissemination of human tumor cells in the chick embryo , 1988, Cell.
[52] O. Matsuo,et al. Plasminogen activator in synovial fluid from patients with rheumatoid arthritis. , 1987, The Journal of rheumatology.
[53] W. Remmele,et al. [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. , 1987, Der Pathologe.
[54] Gerhart U. Ryffel,et al. An estrogen-responsive element derived from the 5′ flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells , 1986, Cell.
[55] Von der Medizinischen. Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain ( ITIH ) genes in multiple human solid tumors : A systematic expression analysis , 2008 .
[56] Ncbi. National Center for Biotechnology Information , 2008 .
[57] H. Ohnishi,et al. Effects of urinary trypsin inhibitor on pancreatic enzymes and experimental acute pancreatitis , 2005, Digestive Diseases and Sciences.
[58] V. Hascall,et al. Inter-alpha-trypsin inhibitor, a covalent protein-glycosaminoglycan-protein complex. , 2004, The Journal of biological chemistry.
[59] L. Ødum,et al. Role of tumour necrosis factor stimulated gene 6 (TSG-6) in the coupling of inter-alpha-trypsin inhibitor to hyaluronan in human follicular fluid. , 2003, Reproduction.
[60] J. Zuber,et al. Gene expression profiling in RAS oncogene-transformed cell lines and in solid tumors using subtractive suppression hybridization and cDNA arrays. , 2002, Advances in enzyme regulation.
[61] M. Daudon,et al. Inhibitory effect of bikunin on calcium oxalate crystallization in vitro and urinary bikunin decrease in renal stone formers , 1999, Urological Research.
[62] S. Kumar,et al. Hyaluronan and angiogenesis. , 1989, Ciba Foundation symposium.
[63] Jean‐Pierre Martin,et al. Human plasma inter-alpha-trypsin inhibitor is encoded by four genes on three chromosomes. , 1989, European journal of biochemistry.
[64] M. Steinbuch. The inter-alpha-trypsin inhibitor. , 1976, Methods in enzymology.
[65] M. Steinbuch. [66]The inter-α-trypsin inhibitor , 1976 .
[66] T. M. Bell. THE CHICK EMBRYO , 1965 .
[67] C. A. de la Motte,et al. Copyright © American Society for Investigative Pathology Mononuclear Leukocytes Bind to Specific Hyaluronan Structures on Colon Mucosal Smooth Muscle Cells Treated with Polyinosinic Acid:Polycytidylic Acid Inter-�-Trypsin Inhibitor Is Crucial to Structure , 2022 .